Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
22.2M
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
338K
-
Shares change
-
+66.3K
-
Total reported value, excl. options
-
$78.4M
-
Value change
-
+$16.3M
-
Number of buys
-
2
-
Number of sells
-
-3
-
Price
-
$231.60
Significant Holders of MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL) as of Q4 2023
6 filings reported holding MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock as of Q4 2023.
MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 338K shares
of 22.2M outstanding shares and own 1.52% of the company stock.
Largest 10 shareholders include JANUS HENDERSON GROUP PLC (2.9M shares), BAKER BROS. ADVISORS LP (1.97M shares), Avoro Capital Advisors LLC (1.89M shares), VANGUARD GROUP INC (1.57M shares), BlackRock Inc. (1.21M shares), PAULSON & CO. INC. (1.11M shares), RTW INVESTMENTS, LP (815K shares), STATE STREET CORP (701K shares), FMR LLC (625K shares), and PRICE T ROWE ASSOCIATES INC /MD/ (389K shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.